Products
-
Pharma Asset Strategy I
CourseThis 10-module course will introduce you to the various concepts, terms, fields and research tools to perform indication analysis in drug development. Assessing the potential of a drug is at the core of pharma/biotech.
$600
-
Strategy Development
CourseUpcoming: This course gives the basics and the process for strategy development. Using a pharma case study, we learn how to develop strategies using various frameworks, and how to present to an audience
$800
-
Pharma Asset Strategy I - Epi and Disease Burden
CourseThis chapter concentrates on key metrics in evaluating disease epidemiology, with absolute vs relative risk, as well as discusses disease burden involved in indication analyses.
$99
-
Pharma Asset Strategy I - Pharmacology, Treatment Flows and TPP
CourseThis chapter focuses on the basics of drug pharmacology, how to look at patient treatment flows and generating a Target Product Profile (TPP).
$99
-
Pharma Asset Strategy I - Clinical Development
CourseThis chapter introduces you to the full lifecycle of clinical development, with focus on clinical trial types, trial endpoints, trial success rates and trial costs.
$99
-
Pharma Asset Strategy I - Patient Journey
CourseThis chapter introduces you on how to map the patient journey, in terms of how patients progress from symptom onset to treatment management. Case example of Nephrotic Syndrome is also provided.
$99